VISCA, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 30.498
EU - Europa 26.229
AS - Asia 17.519
SA - Sud America 2.003
Continente sconosciuto - Info sul continente non disponibili 1.190
AF - Africa 526
OC - Oceania 64
Totale 78.029
Nazione #
US - Stati Uniti d'America 30.023
CN - Cina 7.952
DK - Danimarca 5.252
SG - Singapore 5.225
GB - Regno Unito 5.000
RU - Federazione Russa 4.211
IT - Italia 3.057
NL - Olanda 2.164
VN - Vietnam 1.673
DE - Germania 1.641
BR - Brasile 1.504
SE - Svezia 1.405
UA - Ucraina 1.190
FI - Finlandia 636
HK - Hong Kong 511
FR - Francia 399
IE - Irlanda 389
TR - Turchia 357
IN - India 355
AL - Albania 316
KR - Corea 309
BD - Bangladesh 302
CA - Canada 275
AR - Argentina 176
JP - Giappone 133
SN - Senegal 119
ID - Indonesia 107
IQ - Iraq 106
CI - Costa d'Avorio 103
MX - Messico 103
AT - Austria 78
CO - Colombia 76
PL - Polonia 75
EC - Ecuador 70
ZA - Sudafrica 70
CH - Svizzera 65
ES - Italia 64
PK - Pakistan 63
AU - Australia 55
VE - Venezuela 55
BE - Belgio 52
MY - Malesia 52
MA - Marocco 50
UZ - Uzbekistan 48
PH - Filippine 43
CZ - Repubblica Ceca 42
LT - Lituania 40
SA - Arabia Saudita 39
CL - Cile 35
RO - Romania 33
TN - Tunisia 33
TH - Thailandia 30
PY - Paraguay 29
KE - Kenya 28
PE - Perù 27
EG - Egitto 25
IR - Iran 23
AE - Emirati Arabi Uniti 22
ET - Etiopia 20
IL - Israele 20
NG - Nigeria 20
PT - Portogallo 19
NP - Nepal 18
JO - Giordania 17
KZ - Kazakistan 17
RS - Serbia 17
DZ - Algeria 15
AZ - Azerbaigian 14
OM - Oman 14
BO - Bolivia 13
CR - Costa Rica 13
HN - Honduras 13
HU - Ungheria 13
KG - Kirghizistan 13
LV - Lettonia 13
UY - Uruguay 13
JM - Giamaica 12
GR - Grecia 11
LY - Libia 11
PS - Palestinian Territory 10
DO - Repubblica Dominicana 9
GT - Guatemala 9
PA - Panama 9
BG - Bulgaria 8
GE - Georgia 8
HR - Croazia 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AO - Angola 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
EU - Europa 4
KW - Kuwait 4
LB - Libano 4
MK - Macedonia 4
PR - Porto Rico 4
SC - Seychelles 4
Totale 76.765
Città #
Southend 4.447
Fairfield 3.169
Woodbridge 2.970
Singapore 2.509
Ashburn 2.500
Amsterdam 1.912
Houston 1.862
Wilmington 1.782
Ann Arbor 1.721
Chandler 1.596
San Jose 1.572
Seattle 1.286
Nanjing 1.100
Cambridge 1.099
Beijing 1.043
Dearborn 890
Boardman 847
Dallas 788
Jacksonville 778
Rome 639
Hefei 632
Princeton 597
Hong Kong 494
Shenyang 434
Ho Chi Minh City 423
Jinan 413
Nanchang 393
Dublin 386
Dong Ket 378
Plano 347
Hebei 322
Helsinki 302
Seoul 297
Hanoi 292
Moscow 290
New York 280
Los Angeles 277
Changsha 255
Redwood City 237
Milan 223
Tianjin 218
Jiaxing 215
Izmir 192
San Diego 182
Zhengzhou 177
São Paulo 176
The Dalles 164
Frankfurt am Main 159
Shanghai 158
Munich 145
Santa Clara 143
Bremen 138
Kunming 135
Hangzhou 131
Guangzhou 130
Ningbo 125
Tokyo 121
Dakar 117
Altamura 114
London 111
Istanbul 100
Mumbai 100
San Mateo 96
Paris 89
Montreal 85
Chicago 84
Orem 80
San Paolo di Civitate 80
Taizhou 78
Orange 77
Taiyuan 73
Naples 71
Council Bluffs 69
Haikou 63
Haiphong 61
Warsaw 61
Fuzhou 57
Da Nang 56
Phoenix 55
Brooklyn 54
Atlanta 49
Chennai 49
Columbus 49
San Francisco 49
Falkenstein 48
Toronto 46
Baghdad 45
Brussels 45
Tashkent 45
Stockholm 43
Bologna 41
Boston 41
Denver 41
Mexico City 40
Turin 40
Buffalo 38
Norwalk 37
Rio de Janeiro 36
Charlotte 35
Johannesburg 35
Totale 47.174
Nome #
THE EFFECT OF SATURATION WITH ZN-2+ AND OTHER METAL-IONS ON THE ANTIBACTERIAL ACTIVITY OF OVOTRANSFERRIN 2.091
Trasporto di ferro, formazione di biofilm e virulenza in Pseudomonas aeruginosa 1.274
5-FLUOROCITOSINA COME AGENTE ANTIBATTERICO 633
Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens 386
Acinetobacter baumannii biofilm formation in Human serum and disruption by gallium 353
Biodeterioration of mural paintings in a rocky habitat: The Crypt of the Original Sin (Matera, Italy) 337
A pilot clinical trial on a new point-of-care test for the diagnosis and fast management of urinary tract infections in the Emergency Department. 335
A new device for the prompt diagnosis of urinary tract infections. 332
Antivirulence activity of azithromycin in Pseudomonas aeruginosa 332
A new transcriptional repressor of the Pseudomonas aeruginosa quorum sensing receptor gene lasR. 321
A New Method For Microbiological Analysis That Could Be Used For Point-Of-Care Testing (POCT) 317
Identification by High-Throughput Screening of Pseudomonas Acyl-Coenzyme A Synthetase Inhibitors 305
A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal 302
Biocompatibility and antibacterial properties of TiCu(Ag) thin films produced by physical vapor deposition magnetron sputtering 302
Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence 297
A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal 295
ANTIFUNGAL ACTIVITY OF OVOTRANSFERRIN TOWARDS GENUS CANDIDA 293
Acinetobacter Infection - an Emerging Threat to Human Health 291
Ferric Uptake Regulator Fur Is Conditionally Essential in Pseudomonas aeruginosa 290
A new device for the prompt diagnosis of urinary tract infections 288
Acinetobacter baumannii: evolution of a global pathogen 287
Celebrating centuries: Pink-pigmented bacteria from rosy patinas in the House of Bicentenary (Herculaneum, Italy) 287
The Genomics of Acinetobacter baumannii: Insights into Genome Plasticity, Antimicrobial Resistance and Pathogenicity 286
Synthesis and structural characterization of silver nanoparticles stabilized with 3-mercapto-1-propansulfonate and 1-thioglucose mixed thiols for antibacterial applications 286
New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. 285
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen 282
The dual personality of iron chelators: growth inhibitors or promoters? 281
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen 280
Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa 279
Pyoverdine and proteases affect the response of pseudomonas aeruginosa to gallium in human serum 278
Antivirulence activity of azithromycin in Pseudomonas aeruginosa 278
Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa 276
Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity 275
INTERACTION BETWEEN LACTOFERRIN AND OVOTRANSFERRIN AND CANDIDA CELLS 274
Microbial community structure and dynamics of dark fire-cured tobacco fermentation 271
Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes 269
Analysis of guazatine mixture by LC and LC-MS and antimycotic activity determination of principal components 268
Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound 266
Characterization of a rhodanese from the cyanogenic bacterium Pseudomonas aeruginosa 265
H2O2 AND •NO SCAVENGING BY MYCOBACTERIUM LEPRAE TRUNCATED HEMOGLOBIN O 264
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection 264
Gallium- and Iron-Pyoverdine Coordination Compounds Investigated by X-ray Photoelectron Spectroscopy and X-ray Absorption Spectroscopy 261
Structural Biology of Bacterial Haemophores 259
Growth Phase- and Desiccation-Dependent Acinetobacter baumannii Morphology: An Atomic Force Microscopy Investigation 259
Arthrobacter agilis and rosy discoloration in “Terme del Foro” (Pompeii, Italy) 257
A NEW SOLID MEDIUM FOR ISOLATING AND ENUMERATING THIOBACILLUS-FERROOXIDANS 256
Pseudobactin biogenesis in the plant growth-promoting rhizobacterium Pseudomonas strain B10: Identification and functional analysis of the L-Ornithine N-5-oxygenase (psbA) gene 256
INTRACELLULAR LEVELS AND ACTIVITY OF PVDS, THE MAJOR IRON STARVATION SIGMA FACTOR OF PSEUDOMONAS AERUGINOSA 255
Understanding the biomimetic properties of Gallium in Pseudomonas aeruginosa: a XAS and XPS study 255
Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum sensing system of Pseudomonas aeruginosa 255
New shuttle vectors for gene cloning and expression in multidrug-resistant Acinetobacter species 255
*NO dissociation represents the rate limiting step for O2-mediated oxidation of ferrous nitrosylated Mycobacterium leprae truncated hemoglobin O 254
A new point-of-care test for the rapid detection of urinary tract infections 252
S-palmitoylation modulates human estrogen receptor-[alpha] functions 251
ANTIFUNGAL ACTIVITY OF OVOTRANSFERRIN TOWARDS GENUS CANDIDA 250
Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity 249
Mycobacterial truncated hemoglobins: From genes to functions 248
CO sniffing through heme-based sensor proteins 248
5-fluorocitosina come agente antibatterico. 247
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 247
Repurposing of gallium-based drugs for antibacterial therapy 246
A putative de-N-acetylase of the PIG-L superfamily affects fluoroquinolone tolerance in Pseudomonas aeruginosa. 244
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity 244
Molecular epidemiology of methicillin-resistant Staphylococcus aureus from dairy farms in North-eastern Italy 243
Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp 243
Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa 242
The contribution of active iron-uptake to Acinetobacter baumannii pathogenicity 240
Anthrax toxin: a tripartite lethal combination 239
Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates 238
Amplified fragment-length polymorphism analysis 238
Antimicrobial activity of gallium compounds on ESKAPE pathogens 237
Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. 234
Functional analysis of PvdS, an iron starvation sigma factor of Pseudomonas aeruginosa 234
Identification of Legionella spp. by 19 European reference laboratories: results of the European Working Group for Legionella Infections External Quality Assessment Scheme using DNA sequencing of the macrophage infectivity potentiator gene and dedicated online tools 234
Pyoverdine synthesis and its regulation in fluorescent pseudomonads 233
Sicca syndrome associated with Tropheryma whipplei intestinal infection 232
The truncated hemoglobin from Mycobacterium leprae 232
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 232
The Gac/Rsm and cyclic-di-GMP signalling networks coordinately regulate iron uptake in Pseudomonas aeruginosa 232
IUBMB Life Mini-Theme Issue on the Biology of Acinetobacter Introduction 232
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy 230
Yersinia pseudotuberculosis septicemia and HIV 230
Anthrax toxin: a tripartite lethal combination 230
Iron transport and regulation, cell signalling and genomics: lessons from Escherichia coli and Pseudomonas 229
Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosa 229
Different responses of pyoverdine genes to autoinduction in Pseudomonas aeruginosa and the group Pseudomonas fluorescens-Pseudomonas putida 229
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78 228
Pyoverdine siderophores: from biogenesis to biosignificance 228
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit 228
In situ pilot semi commercial bioleaching test at the San Valentino di Predoi Mine (Northern Italy). 227
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity 227
Ferrous Campylobacter jejuni truncated hemoglobin P displays an extremely high reactivity for cyanide: a comparative study 226
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol 226
Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis 225
Functional and spectroscopic characterization of Chlamydomonas reinhardtii truncated hemoglobins 225
In silico Selection and Experimental Validation of FDA-Approved Drugs as Anti-quorum Sensing Agents 225
Understanding the etiology of rosy discoloration on ancient wall paintings: a molecular approach. 224
ENZYMATIC DETOXIFICATION OF CYANIDE: CLUES FROM PSEUDOMONAS AERUGINOSA RHODANESE 223
An essential transcriptional regulator: The case of Pseudomonas aeruginosa fur 221
Cloning and nucleotide sequence of the pvdA gene encoding the pyoverdin biosynthetic enzyme L-ornithine N5-oxygenase in Pseudomonas aeruginosa 220
Totale 29.268
Categoria #
all - tutte 242.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.182 0 0 110 86 736 115 592 143 362 128 322 588
2022/20235.403 627 792 403 586 476 1.061 34 457 563 38 226 140
2023/20242.893 230 204 202 125 262 364 282 435 46 82 191 470
2024/20259.906 124 243 991 246 205 400 3.106 1.851 831 485 665 759
2025/202618.431 1.784 1.966 1.276 2.152 1.813 872 1.996 400 3.321 1.803 523 525
2026/20271.343 423 491 429 0 0 0 0 0 0 0 0 0
Totale 78.029